IRVINE, Calif. (AP) — Edwards Lifesciences Corp. (EW) on Thursday reported fourth-quarter net income of $35.7 million.

The Irvine, California-based company said it had profit of 17 cents per share. Earnings, adjusted for one-time gains and costs, came to 94 cents per share.

The results surpassed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 90 cents per share.

The medical device maker posted revenue of $888.5 million in the period, also exceeding Street forecasts. Nine analysts surveyed by Zacks expected $862.9 million.

For the year, the company reported profit of $622.1 million, or $2.88 per share. Revenue was reported as $3.44 billion.

For the current quarter ending in April, Edwards Lifesciences expects its per-share earnings to range from $1.04 to $1.14.

The company said it expects revenue in the range of $900 million to $950 million for the fiscal first quarter.

Edwards Lifesciences expects full-year earnings in the range of $4.43 to $4.63 per share, with revenue ranging from $3.5 billion to $3.9 billion.

Edwards Lifesciences shares have increased 13 percent since the beginning of the year, while the Standard & Poor's 500 index has increased 5.5 percent. In the final minutes of trading on Thursday, shares hit $126.98, a rise of 30 percent in the last 12 months.

—————

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EW at https://www.zacks.com/ap/EW

Automated Insights

0
0
0
0
0

Tags

Load comments